Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyotrophic Lateral Sclerosis | 77 | 2024 | 1463 | 13.270 |
Why?
|
Phenylbutyrates | 5 | 2024 | 72 | 3.260 |
Why?
|
Motor Neuron Disease | 7 | 2022 | 97 | 2.600 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2020 | 35 | 1.450 |
Why?
|
Uric Acid | 6 | 2023 | 803 | 1.320 |
Why?
|
Neuroprotective Agents | 4 | 2022 | 955 | 1.140 |
Why?
|
Neurodegenerative Diseases | 7 | 2023 | 1081 | 1.120 |
Why?
|
Low Back Pain | 3 | 2019 | 979 | 1.060 |
Why?
|
Electrodiagnosis | 2 | 2018 | 148 | 0.960 |
Why?
|
Evidence-Based Practice | 2 | 2018 | 494 | 0.920 |
Why?
|
Shoulder Pain | 2 | 2018 | 148 | 0.900 |
Why?
|
Evidence-Based Medicine | 7 | 2021 | 3671 | 0.900 |
Why?
|
Exercise Therapy | 3 | 2020 | 919 | 0.880 |
Why?
|
Disease Progression | 18 | 2024 | 13468 | 0.830 |
Why?
|
Telemedicine | 7 | 2020 | 3018 | 0.750 |
Why?
|
Patient Education as Topic | 3 | 2021 | 2307 | 0.740 |
Why?
|
Muscle Stretching Exercises | 1 | 2020 | 36 | 0.710 |
Why?
|
Practice Guidelines as Topic | 5 | 2019 | 7377 | 0.620 |
Why?
|
Teaching Materials | 1 | 2018 | 84 | 0.600 |
Why?
|
Videoconferencing | 1 | 2019 | 203 | 0.560 |
Why?
|
Humans | 126 | 2024 | 758381 | 0.530 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 4 | 2009 | 43 | 0.510 |
Why?
|
Clinical Trials as Topic | 10 | 2023 | 7985 | 0.510 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2018 | 268 | 0.510 |
Why?
|
Myositis, Inclusion Body | 1 | 2017 | 145 | 0.510 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2018 | 258 | 0.500 |
Why?
|
Double-Blind Method | 11 | 2024 | 12262 | 0.490 |
Why?
|
Burnout, Professional | 4 | 2024 | 701 | 0.480 |
Why?
|
Neuromuscular Diseases | 1 | 2017 | 255 | 0.480 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 536 | 0.470 |
Why?
|
Porphyrias | 1 | 2014 | 57 | 0.470 |
Why?
|
Brachial Plexus Neuritis | 1 | 2014 | 20 | 0.470 |
Why?
|
Myositis | 1 | 2017 | 269 | 0.460 |
Why?
|
Robotics | 4 | 2023 | 874 | 0.460 |
Why?
|
Motor Skills | 1 | 2017 | 519 | 0.450 |
Why?
|
Median Nerve | 1 | 2014 | 132 | 0.440 |
Why?
|
Biological Products | 1 | 2022 | 906 | 0.430 |
Why?
|
Nervous System Diseases | 3 | 2020 | 1647 | 0.410 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3812 | 0.410 |
Why?
|
Neuroglia | 1 | 2017 | 944 | 0.390 |
Why?
|
Middle Aged | 44 | 2024 | 219560 | 0.360 |
Why?
|
Motor Neurons | 6 | 2021 | 864 | 0.350 |
Why?
|
Job Satisfaction | 2 | 2024 | 539 | 0.350 |
Why?
|
Osteoma, Osteoid | 1 | 2011 | 90 | 0.350 |
Why?
|
Delayed Diagnosis | 1 | 2014 | 463 | 0.350 |
Why?
|
Aged | 33 | 2024 | 168217 | 0.330 |
Why?
|
Adult | 41 | 2024 | 219916 | 0.330 |
Why?
|
Internship and Residency | 2 | 2021 | 5865 | 0.330 |
Why?
|
Research | 1 | 2017 | 1976 | 0.320 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.320 |
Why?
|
Male | 53 | 2024 | 358742 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2005 | 1613 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3076 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3196 | 0.310 |
Why?
|
Astrocytes | 4 | 2018 | 1337 | 0.310 |
Why?
|
Muscular Diseases | 1 | 2012 | 551 | 0.300 |
Why?
|
Machado-Joseph Disease | 1 | 2008 | 26 | 0.300 |
Why?
|
Female | 49 | 2024 | 390316 | 0.290 |
Why?
|
DNA Repeat Expansion | 1 | 2008 | 72 | 0.290 |
Why?
|
Electromyography | 4 | 2018 | 1388 | 0.280 |
Why?
|
Synapses | 2 | 2009 | 1757 | 0.280 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 557 | 0.280 |
Why?
|
Research Design | 2 | 2022 | 6154 | 0.270 |
Why?
|
Delivery of Health Care | 4 | 2019 | 5331 | 0.260 |
Why?
|
Survival Analysis | 6 | 2023 | 10112 | 0.260 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15785 | 0.260 |
Why?
|
Spastic Paraplegia, Hereditary | 2 | 2021 | 168 | 0.260 |
Why?
|
Wnt Proteins | 1 | 2009 | 719 | 0.250 |
Why?
|
Bibliometrics | 2 | 2019 | 349 | 0.250 |
Why?
|
Neurofilament Proteins | 2 | 2024 | 333 | 0.250 |
Why?
|
Microsatellite Repeats | 1 | 2008 | 785 | 0.250 |
Why?
|
United States Food and Drug Administration | 2 | 2024 | 1660 | 0.250 |
Why?
|
Activities of Daily Living | 7 | 2023 | 2414 | 0.240 |
Why?
|
Hexosaminidases | 1 | 2024 | 45 | 0.240 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2825 | 0.240 |
Why?
|
Ambulatory Care Facilities | 3 | 2021 | 927 | 0.240 |
Why?
|
Football | 2 | 2021 | 502 | 0.240 |
Why?
|
Neural Conduction | 2 | 2018 | 441 | 0.230 |
Why?
|
Hippocampus | 2 | 2009 | 3736 | 0.230 |
Why?
|
Travel | 2 | 2020 | 785 | 0.230 |
Why?
|
Shoulder Joint | 1 | 2011 | 732 | 0.230 |
Why?
|
Genetic Counseling | 1 | 2008 | 624 | 0.230 |
Why?
|
Body Mass Index | 2 | 2012 | 12876 | 0.220 |
Why?
|
Dyslipidemias | 1 | 2011 | 868 | 0.220 |
Why?
|
Qualitative Research | 2 | 2024 | 2976 | 0.220 |
Why?
|
United States | 16 | 2024 | 72140 | 0.220 |
Why?
|
Spinal Cord | 3 | 2021 | 1815 | 0.220 |
Why?
|
Vitamin D | 1 | 2017 | 3283 | 0.220 |
Why?
|
Hand | 3 | 2020 | 903 | 0.210 |
Why?
|
Radiculopathy | 2 | 2018 | 200 | 0.210 |
Why?
|
CD40 Ligand | 1 | 2024 | 519 | 0.210 |
Why?
|
Linoleic Acids | 1 | 2022 | 39 | 0.210 |
Why?
|
Neurites | 1 | 2005 | 390 | 0.210 |
Why?
|
Neurons | 3 | 2009 | 9418 | 0.210 |
Why?
|
Riluzole | 1 | 2022 | 58 | 0.210 |
Why?
|
Inosine | 1 | 2023 | 130 | 0.200 |
Why?
|
Drugs, Investigational | 1 | 2024 | 212 | 0.200 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6457 | 0.200 |
Why?
|
Curriculum | 3 | 2021 | 3717 | 0.200 |
Why?
|
Esters | 1 | 2022 | 209 | 0.190 |
Why?
|
Brain | 7 | 2021 | 26951 | 0.190 |
Why?
|
Sex Characteristics | 1 | 2012 | 2621 | 0.190 |
Why?
|
Spinal Cord Injuries | 2 | 2020 | 925 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 12076 | 0.190 |
Why?
|
Quality of Life | 8 | 2022 | 13286 | 0.190 |
Why?
|
Glycosylation | 1 | 2004 | 1095 | 0.190 |
Why?
|
Patient Care Team | 3 | 2019 | 2504 | 0.180 |
Why?
|
Phenylenediamines | 1 | 2021 | 86 | 0.180 |
Why?
|
Huntington Disease | 1 | 2007 | 1141 | 0.180 |
Why?
|
Quality Improvement | 3 | 2020 | 3806 | 0.170 |
Why?
|
Administration, Inhalation | 2 | 2023 | 1153 | 0.170 |
Why?
|
Lower Extremity | 2 | 2021 | 1188 | 0.170 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5403 | 0.170 |
Why?
|
Elbow Joint | 1 | 2023 | 356 | 0.170 |
Why?
|
Home Care Services | 2 | 2020 | 647 | 0.170 |
Why?
|
Cromolyn Sodium | 1 | 2019 | 77 | 0.170 |
Why?
|
Antioxidants | 2 | 2018 | 1662 | 0.170 |
Why?
|
Industry | 1 | 2021 | 361 | 0.170 |
Why?
|
Carbamates | 1 | 2021 | 191 | 0.170 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 414 | 0.160 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2020 | 102 | 0.160 |
Why?
|
Cooking | 1 | 2021 | 311 | 0.160 |
Why?
|
Cytoskeleton | 1 | 2004 | 1167 | 0.160 |
Why?
|
Receptors, GABA | 2 | 2018 | 305 | 0.160 |
Why?
|
Endpoint Determination | 1 | 2022 | 590 | 0.160 |
Why?
|
Time | 1 | 2020 | 543 | 0.160 |
Why?
|
Wheelchairs | 2 | 2020 | 78 | 0.160 |
Why?
|
Pyrazines | 1 | 2024 | 1198 | 0.160 |
Why?
|
Sick Leave | 1 | 2019 | 105 | 0.160 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2531 | 0.160 |
Why?
|
Imidazoles | 1 | 2024 | 1179 | 0.160 |
Why?
|
Geographic Information Systems | 1 | 2020 | 281 | 0.150 |
Why?
|
Pamphlets | 1 | 2018 | 71 | 0.150 |
Why?
|
Baseball | 1 | 2019 | 95 | 0.150 |
Why?
|
Enteral Nutrition | 3 | 2020 | 785 | 0.150 |
Why?
|
Computers, Handheld | 1 | 2020 | 210 | 0.150 |
Why?
|
Caregivers | 4 | 2019 | 2224 | 0.150 |
Why?
|
Proportional Hazards Models | 4 | 2023 | 12440 | 0.150 |
Why?
|
Fatty Acids | 2 | 2023 | 1803 | 0.150 |
Why?
|
Behavior | 1 | 2020 | 540 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 259 | 0.150 |
Why?
|
Interneurons | 1 | 2002 | 591 | 0.150 |
Why?
|
Adaptation, Psychological | 2 | 2021 | 2629 | 0.140 |
Why?
|
Cost of Illness | 2 | 2019 | 1936 | 0.140 |
Why?
|
Time Factors | 7 | 2023 | 39873 | 0.140 |
Why?
|
Nerve Tissue Proteins | 2 | 2008 | 4406 | 0.140 |
Why?
|
Survival | 1 | 2017 | 160 | 0.140 |
Why?
|
Athletes | 2 | 2021 | 1125 | 0.140 |
Why?
|
Myofibrils | 1 | 2017 | 141 | 0.140 |
Why?
|
Acetamides | 1 | 2018 | 255 | 0.140 |
Why?
|
Sodium Chloride | 1 | 2018 | 588 | 0.140 |
Why?
|
Survival Rate | 3 | 2017 | 12721 | 0.130 |
Why?
|
Running | 1 | 2021 | 483 | 0.130 |
Why?
|
Rehabilitation | 1 | 2017 | 129 | 0.130 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2048 | 0.130 |
Why?
|
Review Literature as Topic | 1 | 2018 | 346 | 0.130 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2018 | 263 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1972 | 0.130 |
Why?
|
Benzothiazoles | 1 | 2016 | 246 | 0.130 |
Why?
|
Muscle Weakness | 2 | 2019 | 413 | 0.130 |
Why?
|
Shoulder | 1 | 2017 | 299 | 0.120 |
Why?
|
Arm | 2 | 2023 | 583 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2024 | 64379 | 0.120 |
Why?
|
Central Nervous System | 1 | 2002 | 1333 | 0.120 |
Why?
|
Pandemics | 5 | 2022 | 8611 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1230 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2024 | 10747 | 0.120 |
Why?
|
Physicians | 2 | 2023 | 4581 | 0.120 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2015 | 165 | 0.120 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2014 | 45 | 0.120 |
Why?
|
Tracheostomy | 2 | 2019 | 425 | 0.120 |
Why?
|
Housing | 1 | 2019 | 666 | 0.120 |
Why?
|
Drug Combinations | 1 | 2020 | 2020 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10146 | 0.120 |
Why?
|
Muscle Strength | 1 | 2018 | 618 | 0.120 |
Why?
|
Vital Capacity | 3 | 2024 | 962 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2210 | 0.110 |
Why?
|
Self-Help Devices | 1 | 2014 | 62 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1373 | 0.110 |
Why?
|
Cost Savings | 1 | 2019 | 918 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3758 | 0.110 |
Why?
|
Patient Selection | 3 | 2021 | 4244 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1673 | 0.110 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 12951 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 36285 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 80170 | 0.110 |
Why?
|
Orthotic Devices | 1 | 2014 | 129 | 0.110 |
Why?
|
Hospice Care | 1 | 2020 | 677 | 0.110 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2014 | 114 | 0.110 |
Why?
|
Ganglion Cysts | 1 | 2012 | 28 | 0.100 |
Why?
|
Terminal Care | 2 | 2015 | 1750 | 0.100 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2012 | 43 | 0.100 |
Why?
|
Animals | 11 | 2022 | 167777 | 0.100 |
Why?
|
Ulnar Neuropathies | 1 | 2012 | 32 | 0.100 |
Why?
|
Young Adult | 8 | 2021 | 58808 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3602 | 0.100 |
Why?
|
Metabolome | 1 | 2019 | 982 | 0.100 |
Why?
|
Biomedical Research | 3 | 2024 | 3417 | 0.100 |
Why?
|
Psychotic Disorders | 1 | 2007 | 3197 | 0.100 |
Why?
|
Parkinson Disease | 3 | 2017 | 2862 | 0.100 |
Why?
|
Publishing | 1 | 2019 | 833 | 0.100 |
Why?
|
Pilot Projects | 3 | 2021 | 8554 | 0.100 |
Why?
|
Complementary Therapies | 1 | 2015 | 486 | 0.100 |
Why?
|
Ambulatory Care | 2 | 2019 | 2768 | 0.090 |
Why?
|
Polyneuropathies | 1 | 2012 | 137 | 0.090 |
Why?
|
Counseling | 1 | 2019 | 1541 | 0.090 |
Why?
|
Wrist | 1 | 2012 | 219 | 0.090 |
Why?
|
Educational Measurement | 1 | 2018 | 1248 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9160 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2018 | 1056 | 0.090 |
Why?
|
Thiazolidinediones | 1 | 2013 | 460 | 0.090 |
Why?
|
Pyridines | 2 | 2021 | 2860 | 0.090 |
Why?
|
Muscular Dystrophies | 1 | 2012 | 389 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3527 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1793 | 0.090 |
Why?
|
Acceleration | 1 | 2011 | 189 | 0.090 |
Why?
|
Neck | 1 | 2014 | 731 | 0.080 |
Why?
|
Dermatomyositis | 1 | 2012 | 256 | 0.080 |
Why?
|
Cells, Cultured | 5 | 2018 | 18942 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2490 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5199 | 0.080 |
Why?
|
Motor Cortex | 2 | 2017 | 997 | 0.080 |
Why?
|
Databases, Factual | 2 | 2017 | 7980 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2021 | 5759 | 0.080 |
Why?
|
Personal Satisfaction | 2 | 2023 | 641 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1462 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2014 | 595 | 0.080 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39060 | 0.080 |
Why?
|
Dendritic Spines | 1 | 2009 | 243 | 0.070 |
Why?
|
Registries | 2 | 2021 | 8176 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2387 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2885 | 0.070 |
Why?
|
Monitoring, Ambulatory | 1 | 2011 | 352 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2012 | 1196 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1397 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3227 | 0.070 |
Why?
|
Single-Blind Method | 2 | 2023 | 1570 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3100 | 0.070 |
Why?
|
Dendrites | 1 | 2009 | 474 | 0.070 |
Why?
|
Walking | 1 | 2014 | 1188 | 0.070 |
Why?
|
Actigraphy | 1 | 2011 | 518 | 0.070 |
Why?
|
Cell Line | 3 | 2018 | 15594 | 0.070 |
Why?
|
Prospective Studies | 5 | 2022 | 54136 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15225 | 0.070 |
Why?
|
Physical Examination | 1 | 2012 | 1244 | 0.070 |
Why?
|
Mice | 7 | 2019 | 81107 | 0.070 |
Why?
|
Hand Strength | 2 | 2020 | 452 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3586 | 0.070 |
Why?
|
Accidental Falls | 1 | 2014 | 1056 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2782 | 0.060 |
Why?
|
Prognosis | 2 | 2017 | 29558 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2024 | 2322 | 0.060 |
Why?
|
Postoperative Complications | 1 | 2007 | 15638 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6353 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2011 | 649 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4158 | 0.060 |
Why?
|
Data Collection | 3 | 2020 | 3322 | 0.060 |
Why?
|
Stress Fibers | 1 | 2004 | 55 | 0.060 |
Why?
|
Hydrazones | 1 | 2024 | 102 | 0.060 |
Why?
|
RNA, Untranslated | 1 | 2008 | 459 | 0.060 |
Why?
|
Phalloidine | 1 | 2003 | 21 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4775 | 0.060 |
Why?
|
Pediatrics | 1 | 2019 | 3587 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2011 | 1112 | 0.060 |
Why?
|
Torque | 1 | 2023 | 132 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3990 | 0.050 |
Why?
|
Biotinylation | 1 | 2003 | 184 | 0.050 |
Why?
|
Cohort Studies | 5 | 2021 | 41252 | 0.050 |
Why?
|
Elbow | 1 | 2023 | 130 | 0.050 |
Why?
|
Dystroglycans | 1 | 2002 | 62 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2002 | 107 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4902 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2003 | 532 | 0.050 |
Why?
|
Receptors, Neurotransmitter | 1 | 2002 | 174 | 0.050 |
Why?
|
Incidence | 4 | 2022 | 21273 | 0.050 |
Why?
|
Oligonucleotides, Antisense | 1 | 2005 | 459 | 0.050 |
Why?
|
Point Mutation | 1 | 2007 | 1593 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2023 | 226 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12096 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2004 | 11070 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 580 | 0.050 |
Why?
|
Butyrates | 1 | 2022 | 169 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 791 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3069 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2022 | 312 | 0.040 |
Why?
|
Comorbidity | 1 | 2015 | 10495 | 0.040 |
Why?
|
Presynaptic Terminals | 1 | 2002 | 301 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58681 | 0.040 |
Why?
|
Immunoblotting | 1 | 2003 | 1647 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2001 | 257 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2023 | 540 | 0.040 |
Why?
|
Israel | 1 | 2022 | 721 | 0.040 |
Why?
|
Tubulin | 1 | 2003 | 692 | 0.040 |
Why?
|
Adolescent | 4 | 2021 | 87888 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2618 | 0.040 |
Why?
|
Muscle Spasticity | 1 | 2020 | 156 | 0.040 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2019 | 14 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 1074 | 0.040 |
Why?
|
Vitamin E | 1 | 2024 | 870 | 0.040 |
Why?
|
Pyrimidines | 2 | 2024 | 3006 | 0.040 |
Why?
|
Palliative Care | 1 | 2014 | 3570 | 0.040 |
Why?
|
Mastication | 1 | 2019 | 53 | 0.040 |
Why?
|
Psychological Tests | 1 | 2021 | 639 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4106 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2004 | 12760 | 0.040 |
Why?
|
Morphogenesis | 1 | 2002 | 740 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13959 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2021 | 22031 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 663 | 0.040 |
Why?
|
Microtubules | 1 | 2004 | 1072 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 670 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2020 | 287 | 0.040 |
Why?
|
Cadherins | 1 | 2002 | 898 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2003 | 1674 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2740 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 785 | 0.040 |
Why?
|
Neuromuscular Junction | 1 | 2019 | 403 | 0.040 |
Why?
|
Craniocerebral Trauma | 1 | 2021 | 491 | 0.040 |
Why?
|
Risk Factors | 3 | 2021 | 73806 | 0.040 |
Why?
|
Spirometry | 1 | 2020 | 923 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2018 | 522 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9599 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2002 | 1342 | 0.030 |
Why?
|
Actins | 1 | 2004 | 2049 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13276 | 0.030 |
Why?
|
Movement | 2 | 2015 | 1474 | 0.030 |
Why?
|
Telephone | 1 | 2019 | 625 | 0.030 |
Why?
|
Equipment Design | 2 | 2017 | 3507 | 0.030 |
Why?
|
Certification | 1 | 2019 | 418 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4567 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2002 | 1600 | 0.030 |
Why?
|
RNA Interference | 1 | 2005 | 2836 | 0.030 |
Why?
|
Alleles | 1 | 2007 | 6895 | 0.030 |
Why?
|
Bradycardia | 1 | 2017 | 299 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2002 | 3090 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2022 | 1888 | 0.030 |
Why?
|
Axons | 1 | 2003 | 1674 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 986 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 576 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 799 | 0.030 |
Why?
|
Cell Survival | 1 | 2005 | 5781 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2131 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1627 | 0.030 |
Why?
|
Levodopa | 1 | 2015 | 217 | 0.030 |
Why?
|
Antiparkinson Agents | 1 | 2015 | 183 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1829 | 0.030 |
Why?
|
Signal Transduction | 2 | 2009 | 23341 | 0.030 |
Why?
|
Glutamine | 1 | 2017 | 575 | 0.030 |
Why?
|
Speech | 1 | 2019 | 552 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 1990 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18125 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 907 | 0.030 |
Why?
|
Decision Making | 2 | 2019 | 3915 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2600 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2021 | 772 | 0.030 |
Why?
|
Child | 2 | 2019 | 79813 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 2014 | 234 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2189 | 0.020 |
Why?
|
Advance Care Planning | 1 | 2019 | 694 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2017 | 1167 | 0.020 |
Why?
|
Athletic Injuries | 1 | 2021 | 1211 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3705 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4341 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2021 | 1881 | 0.020 |
Why?
|
PPAR gamma | 1 | 2013 | 482 | 0.020 |
Why?
|
Italy | 1 | 2012 | 839 | 0.020 |
Why?
|
Clothing | 1 | 2011 | 97 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1542 | 0.020 |
Why?
|
Stroke | 1 | 2012 | 9696 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1430 | 0.020 |
Why?
|
Metabolomics | 1 | 2019 | 1629 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3712 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3326 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9650 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3071 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3674 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 843 | 0.020 |
Why?
|
Rats | 1 | 2004 | 23681 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20052 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20500 | 0.020 |
Why?
|
Phenotype | 1 | 2005 | 16534 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5070 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9575 | 0.020 |
Why?
|
Cytokines | 1 | 2019 | 7338 | 0.010 |
Why?
|
Apoptosis | 1 | 2001 | 9468 | 0.010 |
Why?
|
Anxiety | 1 | 2019 | 4538 | 0.010 |
Why?
|
Brain Mapping | 1 | 2018 | 6570 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 11894 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10719 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10505 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22006 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8946 | 0.010 |
Why?
|
Replication Origin | 1 | 2001 | 77 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2001 | 237 | 0.010 |
Why?
|
Simian virus 40 | 1 | 2001 | 291 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 255 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8057 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2001 | 869 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12870 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2001 | 472 | 0.010 |
Why?
|
Clone Cells | 1 | 2001 | 1660 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25953 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14641 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2001 | 1150 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14481 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 29915 | 0.010 |
Why?
|
Down-Regulation | 1 | 2001 | 2905 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15396 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5779 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 5779 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11471 | 0.000 |
Why?
|